page_title: Unilife
hierarchical_section_title: Unilife
caption_attribution_description: Unilife is a medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes on Monday, Monday, April 20, 2011 in York, PA. In partnership with Sanofi-aventis, Mikron Group, and MDMA, U.S. Department of Agriculture Rural Development was able to guarantee $18,000,000 through its Business and Industry Guaranteed Loan Program to construct a custom-built, global headquarters and commercial production facility in York, Pennsylvania. The 165,000 sq. ft. facility was completed in late 2010 and can accommodate future growth as well as the Company’s projected demand from pharmaceutical and healthcare companies for its proprietary range of Unifill ready-to-fill (prefilled) and Unitract general purpose safety syringes. Stage one of the facility is designed to accommodate the production of up to 400 million Unilife syringes per year and to meet stringent pharmaceutical standards for primary drug containers. Adjacent to the manufacturing facility is Unilife’s global headquarters (grey exterior) that support administrative, marketing, new product development, quality laboratories and other operational functions. Unilife, which first arrived in Pennsylvania in 2006. The company has doubled its employees for the past three years. There are approximately 150 employees, and they expect to double the number by 2015. USDA Photo by Lance Cheung.
context_page_description: Revenue $190.8 million
  Unilife Corporation was a U.S. based developer, manufacturer and supplier of injectable drug delivery systems. The company was headquartered in King of Prussia, Pennsylvania and had its research and production facility based in York, Pennsylvania. Their targeted client bases were pharmaceutical and biotechnology companies who aim to sell injectable biologics, drugs and vaccine products. Unilife's business model was for pharmaceutical companies to utilize Unilife products in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user for intuitive administration.
  Throughout 2015, Unilife was a growing company specializing in developing various types of medical drug delivery systems which would provide partnering pharmaceutical customers with unique combination products serving as the drug storage container as well as a safe, simple to use and effective form of drug delivery.
context_section_description: Revenue $190.8 million
  Unilife Corporation (NASDAQ:UNIS / ASX: UNIS) was a U.S. based developer, manufacturer and supplier of injectable drug delivery systems. The company was headquartered in King of Prussia, Pennsylvania and had its research and production facility based in York, Pennsylvania. Their targeted client bases were pharmaceutical and biotechnology companies who aim to sell injectable biologics, drugs and vaccine products. Unilife's business model was for pharmaceutical companies to utilize Unilife products in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user for intuitive administration.
  Throughout 2015, Unilife was a growing company specializing in developing various types of medical drug delivery systems which would provide partnering pharmaceutical customers with unique combination products serving as the drug storage container as well as a safe, simple to use and effective form of drug delivery. The company was originally organized with multiple independent business units, developing single use safety syringes (designed for the needle to automatically retract upon completion of delivery) focused on various use cases and design platforms such as subcutaneous delivery, ocular delivery, wearable injectors, reconstitution systems and automatic injection systems.
  During the years 2015 and 2016, the company reduced hiring and went through a few internal business unit reorganizations to shift focus to fewer platforms, eventually settling on a single focus on the development of wearable injector platforms during the summer of 2016. After experiencing financial difficulties, Unilife began Chapter 11 Bankruptcy proceedings in April 2017, and was forced to cease operations in July 2017.
caption: Unilife's facility in York, PA, partially funded by a USDA loan.
exif: {"Image ImageDescription": "Unilife is a medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes on April 20, 2011 in York, PA. In partnership with Sanofi-aventis, Mikron Group, and MDMA, U.S. Department of Agriculture Rural Development was able to guarantee $18,000,000 through its Business and Industry Guaranteed Loan Program to construct a custom-built, global headquarters and commercial production facility in York, Pennsylvania.  The 165,000 sq. ft. facility was completed in late 2010 and can accommodate future growth as well as the Company\u2019s projected demand from pharmaceutical and healthcare companies for its proprietary range of Unifill ready-to-fill (prefilled) and Unitract general purpose safety syringes. Stage one of the facility is designed to accommodate the production of up to 400 million Unilife syringes per year and to meet stringent pharmaceutical standards for primary drug containers. Adjacent to the manufacturing facility is Unilife\u2019s global headquarters (grey exterior) that support administrative, marketing, new product development, quality laboratories and other operational functions. Unilife, which first arrived in Pennsylvania in 2006.  The company has doubled its employees for the past three years. There are approximately 150 employees, and they expect to double the number by 2015. USDA Photo by Lance Cheung.", "Image Make": "NIKON CORPORATION", "Image Model": "NIKON D7000", "Image Software": "Adobe Bridge CS5", "Image DateTime": "2011:10:16 23:54:35", "Image Artist": "Lance Cheung", "Image ExifOffset": "1582", "EXIF ExposureTime": "1/100", "EXIF FNumber": "22", "EXIF ExposureProgram": "Manual", "EXIF ISOSpeedRatings": "500", "EXIF ExifVersion": "0221", "EXIF DateTimeOriginal": "2011:04:20 09:53:12", "EXIF ShutterSpeedValue": "415241/62500", "EXIF ApertureValue": "8918863/1000000", "EXIF ExposureBiasValue": "0", "EXIF MaxApertureValue": "18/5", "EXIF SubjectDistance": "4294967295", "EXIF MeteringMode": "Pattern", "EXIF LightSource": "Unknown", "EXIF Flash": "Flash did not fire, compulsory flash mode", "EXIF FocalLength": "24", "EXIF SubSecTimeOriginal": "8", "EXIF ExifImageWidth": "4888", "EXIF ExifImageLength": "2619", "EXIF SensingMethod": "One-chip color area", "EXIF FileSource": "Digital Camera", "EXIF SceneType": "Directly Photographed", "EXIF ExposureMode": "Manual Exposure", "EXIF WhiteBalance": "Auto", "EXIF DigitalZoomRatio": "1", "EXIF FocalLengthIn35mmFilm": "36", "EXIF SceneCaptureType": "Standard", "EXIF GainControl": "Low gain up", "EXIF Contrast": "Normal", "EXIF Saturation": "Normal", "EXIF Sharpness": "Normal", "EXIF SubjectDistanceRange": "0"}